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Abstract— The experimental model of Wistar rat (WR) is widely used by the scientific community for the evaluation
of xenobiotics and environmental stressors. However, in spite of its great use, few publications have explicitly reported
the differences between the parameters obtained from the ECG delineation and the different variables involved in
the settings of a Wistar rat experiment. Variables such as supplied anesthesia, sex, age, weight, movement restriction
and lead used influence the electrocardiographic parameters analyzed, such as RR, QT, PR intervals, P and QRS
durations and peak amplitudes of P, Q, R, S, and T-waves. The first specific objective of this work is to organize
the electrocardiographic parameters that have already been published by the scientific community according to their
experimental setup. The second specific objective is to provide new parameters, such as the JTend and Tpe intervals,
to the state of the art of Wistar rat ECG characterization. For this purpose, a database of 48 Wistar rats categorized
by sex and age, measured in lead II, was processed and delineated.
Keywords— Wistar rat, ECG.
Resumen— El modelo experimental de rata Wistar es ampliamente utilizado por la comunidad cientı´fica para
la evaluacio´n de xenobio´ticos y estresantes ambientales. Sin embargo, a pesar de su gran uso, pocas publicaciones
han reportado explı´citamente las diferencias entre los para´metros obtenidos del delineamiento del ECG para las
distintas variables que intervienen en la configuracio´n de un experimento con rata Wistar. Variables como la anestesia
suministrada, el sexo, la edad, el peso, la restriccio´n del movimiento y la derivacio´n utilizada influyen significativamente
en los para´metros electrocardiogra´ficos analizados, tales como, los intervalos RR, QT y PR, las duraciones P y QRS,
y las amplitudes pico de las ondas P, Q, R, S y T. El primer objetivo especı´fico de este trabajo es organizar los
para´metros electrocardiogra´ficos que ya han sido publicados por la comunidad cientı´fica segu´n su setup experimental.
El segundo objetivo especı´fico es aportar nuevos para´metros, como los intervalos JTend y Tpe, al estado del arte de
la caracterizacio´n del ECG de rata Wistar. Para ello, una base de datos de 48 ratas Wistar categorizadas por sexo y
edad, medida en la derivacio´n II, fue procesada y delineada.
Palabras clave— rata Wistar, ECG.
I. INTRODUCTION
THE experimental model of Wistar rat (WR) is used inseveral researches on cardiotoxicology and cardiovascu-
lar diseases. In the toxicology field, the WRs are used to induce
them pathologies or cardiovascular disorders by xenobiotics.
This is done, for example, to evaluate the cardiovascular effect
of veraniclina [1], the impact of isoprenaline and caffeine
on cardiac geometry (hypertrophy) [2], the effect of atropine
and propanolol in heart rate variability [3] and the effect
of cyclosporin in the electrocardiographic profile [4], among
others. On the other hand, environmental stressors such as
exposure to air pollution, diet and hypoxia have been studied to
evaluate initiation and progression of cardiovascular diseases.
For example, the effects of atmospheric carbon monoxide
exposure in WRs [5] [6], ECG changes in obese rats [7] and
the effects of systemic hypoxia with different levels of CO2
on RR interval [8]. Besides, WRs have been used as models
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of myocardial infarction by coronary occlusion [9] [10]. In all
cases, the analysis of ECG parameters such as RR, QT and
PR intervals are used to evaluate the results of experiment and
elucidate mechanisms of action.
The use of WRs model in experimental researches is very
common and have increased in the last decades. The WRs pro-
vided advantages over other species such as dogs, Guinea pigs
and rabbit. The WRs are smaller and consequently much easier
and less expensive to handle, they also have less interindividual
variability than dogs, are available as transgenic models to
evaluate diverses experiments, are widely available in large
numbers enabling in depth study and have less potencially
confounding preexisting disease [11].
Several experimental setups of WRs have been developed
by the scientific community. Konopelski et. al [12] have shown
differences between heart rate (HR), PR interval, QRS duration
and QT interval that depend on anesthesia supplied to WRs
such as pentobarbital, urethane, light ether and ketamine and
xylazine. Mutiso et. al [7] have proven that weight afects
the ECG parameters in a experiment with overweight WRs.
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Moreover, Machida et. al [13] have analized WRs with one
and three months old and have found differences between
amplitudes and intervals in ECG of WRs evidencing the role
of the age in ECG parameters. Pereira-Junior et. al [14] have
developed an experimental setup for adquisition of ECG in
conscious WRs with restrained movement while Damasceno
et. al [15] and Tontdonati et. al [16] have implanted electrodes
to measure lead II in conscious and unrestrained WRs, evi-
dencing differences between restrained and unrestrained rats.
The aim of this work is to analyze and extend the state of art
of the characterization of ECG parameters in WR experimental
models.
II. MATERIALS AND METHODS
A. Wistar rat database
The database was acquired at the Institute of Medical
Research Dr. Alfredo Lanari that belongs to the University
of Buenos Aires, Argentina. The database has 48 ECG of
WRs, separated in different groups: 3 female 2-7 weeks old
(88± 3 g), 3 male 2-7 weeks old (100± 1 g), 7 female 7-17
weeks old (219±15 g), 13 male 7-17 weeks old (319±83 g),
15 female 17-45 weeks old (315 ± 40 g) and 7 male 17-45
weeks old (541± 25 g).
Ketamine (75 mg/kg) and Rompun (0, 75 mg/kg xylazine)
has been supplied to WRs as anesthesia to record the ECG.
All ECG signals have been measured in leads I, II, V1, V3
and V6 for approximately during 5 minutes. Nevertheless, this
work only reports the lead II in order to compare with other
works. In Fig. 1 the experimental setup is ilustrated where
four electrodes were used to measure bipolar leads (near to:
left arm, right arm, left leg and right leg) and three precordial
leads located horizontally in the intercostal zone.
Fig. 1. Experimental setup: A Wistar rat (WR) in supine position with 7
electrodes connected.
The ECG signals were recorded with ECCOSUR S.A.
equipment (Buenos Aires, Argentina) digitalized with a sam-
pling rate of 1 kHz and 12 bit resolution.
Animals were treated according to Argentina’s National
Drug, Food and Medical Technology Administration Standards
(Regulation 6344/96) and the National Institutes of Health
Guide for the Care and Use of Laboratory Animals (NIH Pub.
No. 85-23, Revised 1996).
B. Extracting the ECG parameters
We have analyzed ECG WRs with LabChart Pro software
[17]. These software has a processor that handles ECG signals
from rats and other animal species. First, a bandpass filter
in the range of 2-300 Hz was applied to the leads. Then,
through automatic R-waves detections, several ECG beats
were aligned and a template was generated. Each template was
characterized with temporal analysis for the PR, QT, JTend,
Tpe intervals, P and QRS durations and P, Q, R, S, T-waves
peak amplitudes. Sometimes, P-wave and Tend-point were
difficult to find for the automatic delineation. In these cases, an
experienced observer has defined these points from calibrated
cursor. Finally, for each group of WRs, each parameter was
averaged obtaining a mean and standard deviation.
C. Exclusion and inclusion criteria
ECG signals have been included or excluded in the database
depending on its morphology. In Fig. 2 several kind of
waveshapes extracted of the database are ilustrated. The first
one (from top to bottom) is a normal beat and only this
kind of signal has been measured for the extraction of ECG
parameters. The other signals were excluded due the difficulty
of extrating all ECG parameters.
Fig. 2. Differents ECG signals: From top to bottom, normal beat, inverted
P-wave and symmetric QRS complex, without P-wave and asymmetric QRS
complex, inverted P-wave and asymmetric QRS complex, byphasic P-wave,
without P-wave and symmetric QRS complex.
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III. RESULTS
Fig. 3 ilustrates the age vs weight curve of our database in
which each sex was fitted with an exponential curve. Based on
Fig. 3, we have established 2-7 weeks, 7-17 weeks and 17-45
weeks groups in order to classified the WRs.
Table I shows differents experimental settings adopted by
several authors. Besides, we have included the experimental
setting of this work in order to compare with other authors.
Moreover, Table II and Table III shows ECG parameters in
the same order that Table I.
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Fig. 3. Age vs weight: the circles represents female WRs and the squares
represents male WRs.
IV. DISCUSSION
In order to compare the state of art of WRs ECG parameters
with our ECG measurements, the discussion will focus in the
most important measurements of each author.
A. RR interval and HR
The RR interval and HR are negative correlated, thus, if
RR interval has increased, HR will decrease approximately
with the expression HR ≈ 60RR . Therefore, the comparative
analysis is the same for both.
Machida et. al [13] (3 months) and Xu et. al [18] (3
months) have reported similar RR parameter (in this case HR
was converted to RR interval using the above HR equation.
See Table II) in male WRs under pentobarbital anesthesia.
Nevertheless, we have observed (male, 7-17 weeks) a higher
RR parameter than the aforementioned values (see Table II)
using ketamine and xylazine anesthesia (see Table I). In this
way, Konopelski et. al [12] have reported that pentobarbital
anesthesia decrease RR interval in comparation with ketamine
and xylazine.
On the other hand, Miranda et. al [9] and this work (female,
2-7 weeks) have found coincidence in HR (see Table II) in
female WRs under ketamine and xylazine anesthesia, but there
is not a weight coincidence as we can see in Table I.
B. PR interval and P duration
Miranda et. al [9] and this work (female, 2-7 and 7-17
weeks) have reported similar PR interval and P duration
parameters (see Table II) in WRs under ketamine and xylazine
anesthesia. However, Miranda et. al have not reported the age
of WRs and the weight is only similar to female 7-17 weeks
WRs group (see Table I).
C. QRS complex duration
In order to analize the ventricular repolarization, Tavares
et. al [4] and this work (male, 17-45 weeks) have presented
similar QRS duration (see Table II) in male adult WRs with
same anesthesia (see Table I). However, Tavares et. al have
shown a higher HR than this work (male, 17-45 weeks).
Moreover, Buschmann et. al [19] and our results (male, 7-
17 weeks) have presented similar QRS duration (see Table II),
in spite of the differents anesthesia supplied (see Table I) in
agreement with Konopelski et. al [12]. This result could be
explained due to QRS duration is not strongly related to the
anesthesia supplied.
Finally, Silva et. al [20] and Mutiso et. al [7] have observed
very high QRS duration in contrast to the others authors (see
Table II).
D. QT interval
In order to study the QT interval, which represent the
ventricular depolarization and repolarization jointly, several
authors have reported results. For example, Swamy et. al [21]
and this work (male, 7-17 weeks) have presented similar QT
intervals (see Table II) but Swamy et. al have not reported that
kind of anesthesia supplied (see Table I).
Moreover, Machida et. al and this work (male) have not
shown strong variation in QT interval for distinct aged.
Besides, Silva et. al [20] have reported very high QT interval
and, consecuently, a very low HR (see Table II).
E. JTend and Tpe interval
No authors has reported JTend or Tpe intervals to comparate
with our results (see Table II).
F. P-wave peak amplitude
Fraser et. al [22] and this work (male, 7-17 weeks) have
reported similar P-wave peak amplitude (see Table III) using
dissimiler anesthesia (see Table I).
Moreover, Machida et. al [13] and the present work (male,
2-7 and 7-17 weeks) have observed similar P-wave peak
amplitude (see Table III), also using various anesthesia (see
Table I), showing a negative correlation between P-wave peak
amplitude and aged until WRs 17-45 weeks old.
G. Q-wave peak amplitude
Due to the small or lack of Q-wave in WRs, only Mutiso
et. al [7] and our work have measured values of Q-wave peak
amplitude (see Table III).
Our results have shown a negative correlation between the
absolute value of Q-wave peak amplitude and aged in both
sexes. Nevertheless, Mutiso et. al have not reported the same
relation in WRs with 7 weeks of difference old (see Table III).
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TABLE I
DIFFERENTS EXPERIMENTAL SETTINGS BY AUTHOR. IF SOME SETTING WAS NOT SPECIFIED, WE HAVE INDICATED WITH NR (NON-REPORTED).
n Lead Anesthesia Sex Age Weight
Fraser et. al (1967) 100 II Light ether Male NR 150-255
Buschmann et. al (1980) 6 II Urethane Male NR 330-370
Machida et. al (1990) 5 II Pentobarbital Male 1 months 92±1
5 II Pentobarbital Male 3 months 410±14
Tavares et. al (2002) 8 II Ketamine and Xylazine Male Adult 300-400
Miranda et. al (2007) 39 II Ketamine and Xylazine Female NR 173-227
Pereira-Junior et. al (2009) 6 II Concisous Male NR 330-370
Xu et. al (2010) 11 II Pentobarbital Male 3 months 250-350
11 II Pentobarbital Male 9 months 550-750
Silva et. al (2010) 10 NR Pentobarbital NR 3 months 404,46±9,3
Swamy et. al (2013) 6 NR Yes Male NR 150-200
Mutiso et. al (2014) 20 II Ketamine Male NR 214.7±9.96
20 II Ketamine Male NR+7 weeks 229,2±7,26
Selcuk et. al (2015) 5 NR Yes NR 10-12 weeks 320-360
5 NR Yes NR 10-12 weeks 260-380
This work (2017) 3 II Ketamine and Xylazine Female 2-7 weeks 88±3
3 II Ketamine and Xylazine Male 2-7 weeks 100±1
7 II Ketamine and Xylazine Female 7-17 weeks 219±15
13 II Ketamine and Xylazine Male 7-17 weeks 319±83
15 II Ketamine and Xylazine Female 17-45 weeks 315±40
7 II Ketamine and Xylazine Male 17-45 weeks 541±25
TABLE II
ECG TEMPORAL PARAMETERS. IF SOME SETTING WAS NOT SPECIFIED, WE HAVE INDICATED WITH NR (NON-REPORTED).
RR (ms) HR (bpm) PR (ms) P (ms) QRS (ms) QT (ms) JTend (ms) Tpe (ms)
Fraser et. al (1967) NR 334±44,3 65±13 NR 23±5 66±9 NR NR
Buschmann et. al (1980) NR 395±38 51±3,5 NR 15±0,8 NR NR NR
Machida et. al (1990) 113,4±2,0 NR 46,6±1,3 NR 12±0,4 61,2±0,7 NR NR
153,4±6,2 NR 51,4±0,7 NR 13±0,4 62,6±3,0 NR NR
Tavares et. al (2002) NR 444,0±15,0 55,0±2,9 27,5±2,0 20 57,5±2,5 NR NR
Miranda et. al (2007) NR 277±35 48±9 26±8 21±4 85±10 NR NR
Pereira-Junior et. al (2009) 149,88±1,21 NR NR NR NR NR NR NR
Xu et. al (2010) NR 371,3±16,6 49,6±2,4 26,5±1,6 26,4±1,9 96,2±3,5 NR NR
NR 338,3±14,8 51,3±1,2 33,9±1,1 27,1±0,9 98,6±4,6 NR NR
Silva et. al (2010) NR 186,46±8,53 NR NR 92,57±5,42 210,14±8,55 NR NR
Swamy et. al (2013) NR 471,1±8,59 46,67±1,67 NR NR 70,83±1,54 NR NR
Mutiso et. al (2014) 180±7 342±12 30±2,0 28±2,0 81±4,1 105±3,6 NR NR
198±81 313±13 26±1,9 25±1,9 77±3,6 102±5,2 NR NR
Selcuk et. al (2015) NR 307,2±73,3 43,6±3,58 NR 34,8±1,1 72,8±2,68 NR NR
NR 272,8±42,29 42,8±17,9 NR 34,8±1,1 74,8±2,68 NR NR
This work (2017) 221.3±5.9 271.3±7.4 57.4±12.4 25.4±5.2 17.3±2.3 81.9±14.0 64.6±11.7 52.3±7.7
219.2±9.6 274.1±11.7 50.9±3.3 26.1±2.2 16.7±2.1 88.6±3.6 72.0±1.9 56.3±4.0
250.9±14.1 239.8±13.5 50.6±4.3 22.1±3.0 18.3±4.3 81.3±6.9 63.0±7.9 49.4±7.2
231.6±14.0 259.9±15.3 50.2±3.9 23.7±3.9 16.2±1.8 78.3±4.6 62.2±4.8 51.8±5.5
282.2±19.6 213.6±15.3 55.1±5.2 22.8±5.1 18.3±2.2 81.9±8.3 63.7±8.5 52.9±9.7
239.8±16.9 251.3±18.1 63.7±3.2 27.1±5.4 20.7±2.1 87.5±5.4 66.8±6.1 48.3±19.6
H. R-wave peak amplitude
Fraser et. al [22], Machida et. al [13] (1 month) and our
work (male, 2-7 weeks) have observed similar R-wave peak
amplitude (see Table III) under distinct anesthesia supplied in
the three cases (see Table I).
Also, Machida et. al (3 months) and this work (male, 7-17)
have reported similar R-wave peak (see Table III) showing a
negative correlation between R-wave peak and aged.
Moreover, Miranda et. al [9] have shown a very high value
of R-wave peak amplitude and Mutiso et. al [7] have reported
a very low value (see Table III).
I. S-wave peak amplitude
Fraser et. al [22] have observed a positive deflection of S-
wave (see Table III). In our investigation, S-wave peak was
negative in all cases in contrast with Fraser et. al.
Besides, Machida et. al [13] and this work (male) have
shown a negative correlation between aged of WRs and S-
wave peak amplitude in absolute value but have not reported
similar values.
Finally, again Mutiso et. al [7] have observed very low
values and have not reported a negative correlation.
J. T-wave peak amplitude
In order to compare the T-wave peak amplitude, we have
observed that Machida et. al [13] (1 months), Fraser et. al [22]
and our results (male, 2-7 weeks) have reported similar T-wave
peaks amplitude (see Table III) in spite of that the three authors
have supplied distinct anesthesia such as pentobarbital, light
ether and ketamine and xylazine (see Table I).
V. CONCLUSION
Based on results, we have observed several ECG parameters
in agreement with our ECG measurements. Nevertheless, the
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TABLE III
ECG AMPLITUDE PARAMETERS. IF SOME SETTING WAS NOT SPECIFIED, WE HAVE INDICATED WITH NR (NON-REPORTED).
P (µV ) Q (µV ) R (µV ) S (µV ) T (µV )
Fraser et. al (1967) 72±46 NR 920±260 330±150 190±66
Buschmann et. al (1980) NR NR NR NR NR
Machida et. al (1990) 128±5 NR 770±60 -440±5 190±10
64±10 NR 420±40 -150±20 90±10
Tavares et. al (2002) NR NR NR NR 142±25
Miranda et. al (2007) 75±24 NR 1466±199 NR NR
Pereira-Junior et. al (2009) NR NR NR NR NR
Xu et. al (2010) NR NR NR NR NR
NR NR NR NR NR
Silva et. al (2010) NR NR NR NR NR
Swamy et. al (2013) NR NR 280±10 NR NR
Mutiso et. al (2014) 19,8±1,9 -11,2±1,4 71,7±9,0 -20,8±2,1 15,9±1,4
13,9±1,5 -12,8±1 61,3±8,4 -28,4±4,5 18,8±1,4
Selcuk et. al (2015) NR NR NR NR NR
NR NR NR NR NR
This work (2017) 163.6±37.8 -33.3±21.9 768.8±172.2 -581.1±33.0 264.2±96.8
120.5±16.5 -31.3±9.7 806.7±138.7 -564.2±298.6 205.8±60.1
62.6±29.2 -22.2±10.0 540.1±141.1 -339.1±169.2 127.9±45.8
75.1±16.1 -24.8±14.4 547.6±102.2 -328.6±148.7 132.9±31.0
59.6±37.4 -8.3±20.4 528.1±144.0 -289.0±152.1 131.5±41.3
81.3±19.4 -0.1±8.3 473.2±174.6 -209.0±64.9 120.2±59.8
most authors have reported few parameters and have not
reported the complete experimental setting. In this sense, we
have provided several ECG parameters in three age ranges and
both sexes using ketamine and xylazine anesthesia supplied.
Besides, we have showed differents kind of possible wave-
shapes in lead II in contrast with others authors that have not
reported the ECG-waves morphology. In other words, we have
provided ECG parameters under well established experimental
conditions.
On the other hand, several problems exist to delineate the
ECG of WRs. The peak values has been poorly reported,
specialy Q-wave peak due its low level or absence [11].
Besides, the lack of ST segment difficult the localization
of QRSend and consecuently the J-point position. Moreover,
different criteria exist to define the end of the rodent T wave.
In this sense, no standard protocol has been developed to
establish how delineate the ECG-waves.
Finally, we have concluded that in spite of the importance
of WRs in several fields such as toxicology, behavior and basic
research in cardiovascular diseases, even nowadays it does not
exist a standard of ECG parameters.
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